As of Sept. 20, 2022, there have been more than 1.1 million cases of COVID-19 in Quebec. It is estimated that 10 to 30 per cent of cases will have lingering symptoms after the acute illness. This means that as many as 330,000 Quebecers may experience what’s become known as long COVID, or post-COVID-19 syndrome.
The Department of Pediatrics would like to introduce our newest member, Dr. Hugh McMillan, appointed Associate Professor in the Division of Pediatric Neurology, starting August 1, 2021.
Congratulations to Dr. Myriam Srour, Assistant Professor in the Department of Pediatrics, Division of Pediatric Neurology, and Dr. Robert Koenekoop from the Department of Pediatric Surgery for their success as co-PIs on a grant entitled Neurodevelopmental basis of nervous system disorders (NeuroBasis) awarded by the Canadian Foundation for Innovation. The aim of their work will be to discover new mutations and new genes that cause neural and retinal degenerations in children suffering from inherited retinal dystrophies, pediatric seizures, autism and other disorders.
Canadian and international scientists are joining forces to promote research into how COVID-19 affects the central nervous system, as they strive to understand whether and how the new coronavirus and other respiratory viruses could lead to lasting brain damage. Brought together as part of a new initiative called VINEx, created by Rocket Science Health, a Victoria-based medical devices company, the group is aiming to lead the charge in understanding how viruses invade the brain – an area of study that has received relatively little attention.
Each year, the McGill Faculty of Medicine and Health Sciences awards three prestigious prizes, Maude Abbott, Haile. T. Debas and Rosemary Wedderburn Brown Prize, to deserving faculty members, which celebrate exceptional contributions to our tripartite mission of education, research and service to society, as well as the legacy of McGill luminaries who continue to inspire us today.
Launching on June 26, 2020, the Helmholtz International BigBrain Analytics Learning Laboratory (HIBALL) will work to create 3D brain models at an unprecedented cellular-level resolution.
Dr. Maryam Oskoui, Associate Professor in the Department of Pediatrics, has been appointed as the Division Director of Pediatric Neurology for a 5-year term.
An international team spearheaded by researchers at McGill University has discovered a biological mechanism that could explain heightened somatic awareness, a condition where patients experience physical discomforts for which there is no physiological explanation.
Please join the Department of Pediatrics in congratulating the following Faculty Members on their promotion to Associate Professor. Each richly deserve this recognition of personal accomplishment.
Dr. Ilana Bank, Division of Emergency Medicine
Dr. Moshe Ben-Shoshan, Division of Allergy, Immunology and Dermatology
Dr. Sasha Dubrovsky, Division of Emergency Medicine
Dr. Maryam Oskoui, Division of Neurology
Dr. David Zielinski, Division of Respirology
Tal Arbel - pioneering researcher challenges gender stereotypes, as reported by the McGill Reporter
When NHL star player Sidney Crosby suffered a concussion during a game in May – the fourth concussion of his career – the news made nationwide headlines. A few years earlier, a concussion had kept the Pittsburgh Penguins star off the ice for ten months.
Concussions can have serious consequences, even in cases where the victim shows few symptoms immediately. Victims often shrug off a mild blow to the head, unaware that brain damage has occurred.
A foray into plant biology led one researcher to discover that a natural molecule can repair axons, the thread-like projections that carry electrical signals between cells. Axonal damage is the major culprit underlying disability in conditions such as spinal cord injury and stroke.
A foray into plant biology led one researcher to discover that a natural molecule can repair axons, the thread-like projections that carry electrical signals between cells. Axonal damage is the major culprit underlying disability in conditions such as spinal cord injury and stroke.
The Neuro is recognized as a major Canadian center for ALS research and patient care. During June, designated ALS Month, The Neuro redoubles its efforts to inform the public and the media about amyotrophic lateral sclerosis (ALS), and urges all to help support ALS research.
The potential of light as a non-invasive, highly-focused alternative to pain medication was made more apparent thanks to research conducted by scientists at the Montreal Neurological Institute and Hospital of McGill University and the McGill University Health Centre.
